CVS, Aetna shares rise on report DoJ won’t challenge their merger deal
Cameron Costa | CNBC
Larry Merlo, CEO of CVS and Mark Bertolini, CEO of AETNA seem on Squawk Field on Dec. 4th, 2017.
Shares of CVS Well being and Aetna rose Thursday on a report the Division of Justice will not problem their merger.
Bloomberg reported the information, citing commerce publication Reorg Analysis. Aetna declined remark. CVS mentioned it doesn’t touch upon “market rumors.”
Drugstore chain and pharmacy advantages supervisor CVS introduced in December it might purchase well being insurer Aetna for $69 billion in a deal that might reshape the well being trade. Some had feared the Division of Justice would search to problem the deal prefer it did AT&T’s acquisition of Time Warner.
CVS shares rose practically three %, whereas Aetna’s shares elevated 2 %. Shares of Cigna and Categorical Scripts additionally rose on the information. The well being insurer Cigna is within the means of buying pharmacy advantages supervisor Categorical Scripts.
Categorical Scripts declined remark.
-CNBC’s Bertha Coombs contributed to this report
Supply hyperlink – https://www.cnbc.com/2018/07/12/cvs-aetna-shares-rise-on-report-doj-wont-challenge-their-merger-deal.html